Following sequential carboplatin treatment of 2D cultured ovarian cancer cell lines, only SOX2 expression remained elevated after the third treatment, suggesting a role for SOX2 in platinum resistance [56]. This evidence concerns the gene SOX2 and ovarian cancer.